Home/Filings/4/0000899243-22-020994
4//SEC Filing

Bodenrader Mark 4

Accession 0000899243-22-020994

CIK 0001805387other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:45 PM ET

Size

6.0 KB

Accession

0000899243-22-020994

Insider Transaction Report

Form 4
Period: 2022-06-01
Bodenrader Mark
See Remarks
Transactions
  • Award

    Restricted Stock Units

    2022-06-01+18,93218,932 total
    Common Stock (18,932 underlying)
Footnotes (2)
  • [F1]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock.
  • [F2]25% of the RSUs shall vest on each of the first, second, third and fourth anniversary of June 1, 2022, subject to the Reporting Person's continued service relationship with the Issuer through each such date.

Issuer

Cerevel Therapeutics Holdings, Inc.

CIK 0001805387

Entity typeother

Related Parties

1
  • filerCIK 0001830371

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:45 PM ET
Size
6.0 KB